- Home
- TCRX vs EXFY Comparison
TCRX vs EXFY Comparison
Compare TCRX & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- EXFY
- Stock Information
- Founded
- TCRX 2018
- EXFY 2008
- Country
- TCRX United States
- EXFY United States
- Employees
- TCRX N/A
- EXFY N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- EXFY Computer Software: Prepackaged Software
- Sector
- TCRX Health Care
- EXFY Technology
- Exchange
- TCRX Nasdaq
- EXFY Nasdaq
- Market Cap
- TCRX 140.7M
- EXFY 165.4M
- IPO Year
- TCRX 2021
- EXFY 2021
- Fundamental
- Price
- TCRX $1.92
- EXFY $1.62
- Analyst Decision
- TCRX Strong Buy
- EXFY Strong Buy
- Analyst Count
- TCRX 5
- EXFY 3
- Target Price
- TCRX $9.40
- EXFY $4.75
- AVG Volume (30 Days)
- TCRX 648.1K
- EXFY 412.3K
- Earning Date
- TCRX 11-07-2025
- EXFY 11-06-2025
- Dividend Yield
- TCRX N/A
- EXFY N/A
- EPS Growth
- TCRX N/A
- EXFY N/A
- EPS
- TCRX N/A
- EXFY N/A
- Revenue
- TCRX $6,961,000.00
- EXFY $144,251,000.00
- Revenue This Year
- TCRX $255.18
- EXFY $5.45
- Revenue Next Year
- TCRX N/A
- EXFY $2.56
- P/E Ratio
- TCRX N/A
- EXFY N/A
- Revenue Growth
- TCRX N/A
- EXFY 4.13
- 52 Week Low
- TCRX $1.02
- EXFY $1.60
- 52 Week High
- TCRX $6.23
- EXFY $4.13
- Technical
- Relative Strength Index (RSI)
- TCRX 41.52
- EXFY 36.65
- Support Level
- TCRX $2.23
- EXFY $1.63
- Resistance Level
- TCRX $2.43
- EXFY $1.76
- Average True Range (ATR)
- TCRX 0.19
- EXFY 0.07
- MACD
- TCRX -0.04
- EXFY 0.00
- Stochastic Oscillator
- TCRX 1.52
- EXFY 11.76
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About EXFY Expensify Inc.
Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.